Alaunos Therapeutics, Inc. Derivative, Gain (Loss) on Derivative, Net
Alaunos Therapeutics, Inc. (TCRT) reported Derivative, Gain (Loss) on Derivative, Net of $0 for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-01.
Discontinued › Income Statement › Other Income
us-gaap:DerivativeGainLossOnDerivativeNet · last filed 2021-03-01
- Alaunos Therapeutics, Inc. derivative, gain (loss) on derivative, net for the quarter ending 2018-12-31 was $112.00K.
- Alaunos Therapeutics, Inc. derivative, gain (loss) on derivative, net for the quarter ending 2018-09-30 was -$165.00K, a 181.68% decline year-over-year.
- Alaunos Therapeutics, Inc. derivative, gain (loss) on derivative, net for the quarter ending 2018-06-30 was $183.00K, a 177.27% increase year-over-year.
- Alaunos Therapeutics, Inc. derivative, gain (loss) on derivative, net for the quarter ending 2018-03-31 was $28.00K.
- Alaunos Therapeutics, Inc. derivative, gain (loss) on derivative, net for fiscal 2020 was $0.00.
- Alaunos Therapeutics, Inc. derivative, gain (loss) on derivative, net for fiscal 2019 was $0.00, a 100.00% decline from fiscal 2018.
- Alaunos Therapeutics, Inc. derivative, gain (loss) on derivative, net for fiscal 2018 was $158.00K.
- Alaunos Therapeutics, Inc. derivative, gain (loss) on derivative, net for fiscal 2017 was -$1.29M.
| Period end | Derivative, Gain (Loss) on Derivative, Net 3 month | Derivative, Gain (Loss) on Derivative, Net 3 month as first filed | Derivative, Gain (Loss) on Derivative, Net 6 month | Derivative, Gain (Loss) on Derivative, Net 9 month | Derivative, Gain (Loss) on Derivative, Net 12 month | Derivative, Gain (Loss) on Derivative, Net 12 month as first filed |
|---|---|---|---|---|---|---|
| 2020-12-31 | $0.00 10-K · filed 2021-03-01 | |||||
| 2019-12-31 | $0.00 10-K · filed 2021-03-01 | |||||
| 2018-12-31 | $112.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | -$53.00K derived: sum of 2 quarters · filed 2021-03-01 | $130.00K derived: sum of 3 quarters · filed 2021-03-01 | $158.00K 10-K · filed 2021-03-01 | ||
| 2018-09-30 | -$165.00K 10-Q · filed 2019-11-07 | $18.00K derived: sum of 2 quarters · filed 2019-11-07 | $46.00K 10-Q · filed 2019-11-07 | $43.00K derived: sum of 4 quarters · filed 2020-03-02 | ||
| 2018-06-30 | $183.00K 10-Q · filed 2019-08-08 | $211.00K 10-Q · filed 2019-08-08 | $208.00K derived: sum of 3 quarters · filed 2020-03-02 | $410.00K derived: sum of 4 quarters · filed 2020-03-02 | ||
| 2018-03-31 | $28.00K 10-Q · filed 2019-05-08 | $25.00K derived: sum of 2 quarters · filed 2020-03-02 | $227.00K derived: sum of 3 quarters · filed 2020-03-02 | $293.00K derived: sum of 4 quarters · filed 2020-03-02 | ||
| 2017-12-31 | -$3.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | $199.00K derived: sum of 2 quarters · filed 2020-03-02 | $265.00K derived: sum of 3 quarters · filed 2020-03-02 | -$1.29M 10-K · filed 2020-03-02 | ||
| 2017-09-30 | $202.00K 10-Q · filed 2018-11-09 | $268.00K derived: sum of 2 quarters · filed 2018-11-09 | -$1.29M 10-Q · filed 2018-11-09 | -$1.44M derived: sum of 4 quarters · filed 2019-03-05 | ||
| 2017-06-30 | $66.00K 10-Q · filed 2018-08-08 | -$1.49M 10-Q · filed 2018-08-08 | -$1.64M derived: sum of 3 quarters · filed 2019-03-05 | -$1.62M derived: sum of 4 quarters · filed 2019-03-05 | ||
| 2017-03-31 | -$1.56M 10-Q · filed 2018-05-10 | $1.56M 10-Q · filed 2017-05-01 | -$1.71M derived: sum of 2 quarters · filed 2019-03-05 | -$1.68M derived: sum of 3 quarters · filed 2019-03-05 | ||
| 2016-12-31 | -$145.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-05 | -$124.00K 10-K · filed 2019-03-05 | -$124.00K 10-K · filed 2019-03-05 | $124.00K 10-K · filed 2017-02-16 | ||
| 2016-09-30 | $21.00K 10-Q · filed 2017-11-06 | $21.00K 10-Q · filed 2017-11-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |